Article
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine.
Cell reports - 31 Jan 2023
Tauzin Alexandra, Nicolas Alexandre, Ding Shilei, Benlarbi Mehdi, Medjahed Halima, Chatterjee Debashree, Dionne Katrina, Gong Shang Yu, Gendron-Lepage Gabrielle, Bo Yuxia, Perreault Josée, Goyette Guillaume, Gokool Laurie, Arlotto Pascale, Morrisseau Chantal, Tremblay Cécile, Martel-Laferrière Valérie, De Serres Gaston, Levade Inès, Kaufmann Daniel E, Côté Marceline, Bazin Renée, Finzi Andrés
Abstract excerpt
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants have recently emerged, becoming the dominant circulating strains in many countries. These variants contain a large number of mutations in their spike glycoprotein, raising concerns about vaccine efficacy. In this study, we evaluate the ability of plasma from a cohort of individuals that received three doses of mRNA vaccine to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
